PEG-Intron

País: Nova Zelândia

Língua: inglês

Origem: Medsafe (Medicines Safety Authority)

Compre agora

Ingredientes ativos:

Peginterferon alfa-2b 150ug

Disponível em:

Schering-Plough a division of Schering-Plough Animal Health Limited

DCI (Denominação Comum Internacional):

Peginterferon alfa-2b 150 µg

Dosagem:

150 mcg

Forma farmacêutica:

Powder for injection

Composição:

Active: Peginterferon alfa-2b 150ug Excipient: Dibasic sodium phosphate Monobasic sodium phosphate dihydrate Polysorbate 80 Sucrose Water for injection

Unidades em pacote:

Ampoule, Diluent, 2 mL

Classe:

Prescription

Tipo de prescrição:

Prescription

Fabricado por:

Schering-Plough Company

Resumo do produto:

Package - Contents - Shelf Life: Ampoule, Diluent - 2 mL -   - Combination pack, 1 x (Powder + Diluent) - 150 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Combination pack, 2 x (Powder + Diluent) - 300 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Combination pack, 4 x (Powder + Diluent) - 600 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, 1 x 150?g - 150 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Data de autorização:

1999-11-16

Ver histórico de documentos